Invicro has spent over twenty years specializing in neuroscience imaging solutions for preclinical, early phase and late phase clinical studies. Our capabilities span from in vitro assays to in vivo imaging using PET, SPECT and MRI imaging biomarkers in drug development and clinical trials. We have expertise in coordinating worldwide multicenter imaging studies, and providing management and oversight of radiotracer supply for both commercial and non-commercially available agents.
